secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2025-05-22T23:59:59+00:00
Accession:  0001193125-25-125040
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin shareholders approve 8M share increase in equity plan, re-elect all directors
--------------------------------------------------------------------------------

- Shareholders approved 8M additional shares under the 2017 Equity Incentive Plan (157.3M for, 7.7M against).
- All ten director nominees, including Elizabeth Anderson and Alexander Hardy, re-elected.
- KPMG ratified as independent auditor for FY2025 with 168.6M votes in favor.
- Advisory vote on executive compensation passed with over 93% support of votes cast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000119312525125040/0001193125-25-125040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000119312525125040/d947689d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-125040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer